Mechanical biomarkers for oocyte and embryo viability

ABSTRACT

Provided are methods for the determination of the viability of a mammalian embryo or a potential embryo generated from a mammalian oocyte, comprising applying a mechanical stimulus to the embryo or oocyte, detecting a temporal response of the embryo or oocyte to the mechanical stimulus, and deriving measurements for one or more parameters from the temporal response, the measurements being indicative of viability. Also provided are methods for selecting an embryo for transfer and methods for enhancing the viability of an embryo or oocyte.

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No.13/739,965, filed Jan. 11, 2013, which in turn claims the benefit under35 U.S.C. §119(e) of U.S. Provisional Application Ser. No. 61/586,561,filed Jan. 13, 2012, each of which is incorporated by reference in itsentirety.

FIELD OF THE DISCLOSURE

The present disclosure, in general, relates to methods for providingmeasurements for the determination of the development potential (e.g.,viability) of a mammalian embryo or a potential embryo generated from amammalian oocyte. Also provided are methods for selecting an embryo fortransfer for in vitro fertilization (IVF) and methods for enhancing theviability of an embryo or oocyte.

BACKGROUND

The following discussion of the background of the disclosure is merelyprovided to aid the reader in understanding the disclosure and is notadmitted to describe or constitute prior art to the present disclosure.

Nearly 1 out of 6 couples in the U.S. seeking to have childrenexperience infertility. For those who have been unsuccessful conceivinga child with the aid of pharmaceuticals, surgery, or artificialinsemination, in vitro fertilization (IVF) is their best option tofinally become pregnant. However, the average live-birth rate for an IVFcycle is approximately 1-in-3 and this rate has only modestly increasedsince the advent of IVF more than 30 years ago.

An IVF cycle consists of hormonal stimulation so that several eggs canbe surgically harvested, and then these ova are fertilized in vitro sothat they can develop in culture for evaluation. Typically after threedays, the embryos are examined under the microscope by the embryologistto select the most viable embryos to transfer back to the mother. Theembryologist faces a significant dilemma where he or she must selectwhich of these available embryos is viable, based on morphologicalassessment.

Ideally, only one embryo should be transferred back to the mother toeliminate the risks associated with multiple gestation pregnancies suchas pre-term birth, low birth weight, and the necessity for fetalreduction in some cases. Due to the subjective and inaccurate nature ofthis morphological assessment, however, multiple embryos are transferredback to the mother in 90% of cases in order to increase the chances fora successful implantation.

Another IVF technique extends the length of embryo culture to five dayswhich is the blastocyst stage (Behr et al., Human Reproduction,14(2):454-7, 1999). The embryos that survive to the blastocyst stage arethought to be more viable and therefore have a higher rate ofimplantation. Culturing to the day-five blastocyst stage has been usedclinically to transfer fewer embryos but has also demonstrated how poorthe more common day-three selection is in predicting survival.

Moreover, unfortunately, not all women qualify for blastocyst transferbecause they may not have a sufficient number of embryos at day-three torisk further attrition. Even for those who do qualify, blastocysttransfer is still controversial as some propose that embryos should betransferred earlier to avoid undue stress on the embryos. Therefore,embryologists need an objective and quantitative measure of embryoviability at an early stage to improve a patient's chance of achieving asingle live-birth.

SUMMARY

The present disclosure provides, in one embodiment, a method fordetermination of the viability of a mammalian embryo or a potentialembryo generated from a mammalian oocyte, comprising applying amechanical stimulus to the embryo or oocyte; detecting a temporalresponse of the embryo or oocyte to the mechanical stimulus; andderiving measurements for one or more parameters from the temporalresponse, the measurements being indicative of viability.

In some aspects, the mechanical stimulus comprises a negative,substantially constant, pressure on a portion of the surface of theembryo or oocyte, for a period of time sufficient to inflate the embryoor oocyte at the portion but not to damage the embryo or oocyte.

In one aspect, the one or more parameters comprise at least one of speedand depth of inflation.

In one aspect, the method further comprises comparing the measurementsto those measured for a reference embryo or oocyte under similarconditions. In some aspects, the reference embryo or oocyte is a virtualembryo or oocyte generated by pooling measurement data from a referencepopulation of embryos or oocytes, or an embryo or oocyte from the samemammalian donor as the embryo or oocyte being measured. In some aspects,the method further comprises determining that the embryo is more likelyviable, or the oocyte is more likely to generate a viable embryo, thanthe reference embryo or oocyte, if the measured speed is lower than thatof the reference embryo or oocyte, or if the measured depth is shorterthan that of the reference embryo or oocyte.

In one aspect, the speed comprises an initial inflation speed defined asa ratio of depth of inflation to length of time starting from thebeginning of application of the negative pressure. In some aspects, thelength of time is less than about 0.5 second.

In another aspect, the depth comprises the depth of inflation during aperiod after an initial inflation slows down and substantiallystabilizes. In some aspects, the period starts from at least about 0.5second after initiation of the negative pressure and is no more thanabout 5 seconds.

In some aspects, the pressure is from −0.3 psi to −1 psi. In someaspects, the portion of the surface area of the embryo or oocyte is from25 μm to 100 μm in diameter. In some aspects, the embryo is at or lessthan 1 day old following fertilization.

In some aspects, the embryo is a human embryo. For a human embryo, inone aspect, the portion of the surface area of the embryo or oocyte isfrom about 35 μm to about 65 μm in diameter. In one aspect, the pressureis from −0.35 psi to −0.75 psi.

Also provided, in another embodiment, is a method for selecting a humanembryo from a plurality of embryos for transfer to a human subject,comprising applying a mechanical stimulus to each embryo or oocyte ofthe plurality; detecting a temporal response of each embryo or oocyte tothe mechanical stimulus; deriving measurements for one or moreparameters from the temporal response, the measurements being indicativeof viability; and selecting an embryo from the plurality of embryos forthe transfer based on the measurements.

Another embodiment provides a method for tuning an embryo or oocyte,comprising applying a negative, substantially constant, pressure on aportion of the surface of the embryo or oocyte, for a period of timesufficient to inflate the embryo or oocyte at the portion but not todamage the embryo or oocyte. In one aspect, the embryo is a human embryothat is less than 3 days old following fertilization. In one aspect, theportion of the surface area of the embryo or oocyte is from 40 μm to 60μm and the pressure is from −0.3 psi to −0.5 psi.

BRIEF DESCRIPTION OF THE DRAWINGS

Provided as embodiments of this disclosure are drawings which illustrateby exemplification only, and not limitation, wherein:

FIG. 1 illustrates an improved IVF procedure taking advantage of thepresent technology;

FIG. 2A and FIG. 2B show two microscope images illustrating thedifference, as determined by the present technology, between viable andnon-viable embryos;

FIG. 3A shows an aspiration curve created with data observed in atemporal response of an embryo upon application of a mechanicalstimulus;

FIG. 3B shows a linear elastic solid model used to fit the data in FIG.3A;

FIG. 4 shows how each parameter in a linear elastic solid model can beinterpreted, mechanically and how the mechanical parameters arereflected in the aspiration curves;

FIG. 5A, FIG. 5B, FIG. 5C, FIG. 5D, FIG. 5E, FIG. 5F, and FIG. 5Gillustrate different ways to apply a mechanical stimulus to an embryo oroocyte;

FIG. 6A shows an example setup for applying a mechanical stimulus anddetecting a temporal response;

FIG. 6B shows a microwell plate useful for carrying out the mechanicalmanipulation experiment and embryo tracking while maintaining groupculture following manipulation;

FIG. 7A and FIG. 7B show aspiration curves obtained from a number ofembryos in Example 1, correlated to blastocyst survival rates. Asterisksindicate viable embryos;

FIG. 8 presents bar charts to show the discrimination power of theparameters, k₁, η₁, and τ,

FIG. 9 presents a scatter plot to show that, the combination ofparameters, k₁ and η₁, provides even better predictive ability. Lightdots represent viable embryos and dark dots represent non-viableembryos;

FIG. 10 presents a scatter plot to show that, the combination ofparameters, k₁ τ, and η₁, provides even better predictive ability. Lightdots represent viable embryos and dark dots represent non-viableembryos. The circle indicates a concentration area where viable embryosare located;

FIG. 11A and FIG. 11B show separation of viable embryos from non-viableembryos on the 3D scatter plot with training (FIG. 11A) andtraining+testing samples (FIG. 11B);

FIG. 12 presents aspiration curves from embryos at one-cell stage;

FIG. 13 presents aspiration curves from oocytes;

FIG. 14 presents bar charts to show the discrimination power of theparameters, k₁ and η₁, for oocytes;

FIG. 15 shows that oocytes, in general, have higher and more steepcurves than embryos;

FIG. 16 shows that, despite the difference between oocytes and embryos,viable oocytes and embryos can readily be separated from non-viableoocytes and embryos; and

FIG. 17 shows an example heat map of expression profiling with theasterisk indicating a cluster of genes.

Some or all of the figures are schematic representations forexemplification; hence, they do not necessarily depict the actualrelative sizes or locations of the elements shown. The figures arepresented for the purpose of illustrating one or more embodiments withthe explicit understanding that they will not be used to limit the scopeor the meaning of the claims that follow below.

DETAILED DESCRIPTION

The following examples serve to illustrate the present disclosure. Theseexamples are in no way intended to limit the scope of the disclosure.

A quantitative and non-invasive predictor of viability has beendeveloped for oocytes and embryos that entails mechanical stimuli. Theviability test is shown to be effective at as early as day 1 afterfertilization, as well as in oocytes prior to fertilization. The earlyviability test can help predict which embryos would have survived to theblastocyst stage without having to keep them in a stressful cultureenvironment for several days for further viability evaluation.

Surprisingly, the mechanical stimuli employed in this viability testhave been shown to increase embryo viability. Therefore, the presentdisclosure provides mechanical manipulation of embryos and oocytes thatserve both as biomarkers for viability testing and as a mechanism toimprove their viability.

With the presently disclosed devices and methods, an improved IVFprocedure can be achieved, as illustrated in FIG. 1. Upon retrieval fromthe follicles in the mother, oocytes are incubated under suitablecondition to allow fertilization. Then, after fertilization, evenimmediately after fertilization, mechanical stimulus is applied to eachof the fertilized embryos (FIG. 1, step 3), at which step a temporalresponse is detected. Subsequently, certain measurements are derivedfrom the detected temporal response, with appropriate mathematicaltransformation as applicable. Based on such measurements, which reflectthe viability of the embryos, the embryo with the predicted highestviability is selected and transferred to a carrier within the same day(FIG. 1, step 4), such as the oocyte donor, to proceed for furtherembryonic development.

Temporal Response and Derived Measurements

The mechanical stimuli employed in various aspects of the presentdisclosure can allow measuring of mechanical properties of severaldifferent bodies and parts thereof, including the entire embryo body,the zona pellucida, the cytoplasm or the embryo, cortical granules,blastomeres, the cytoplasm of each blastomere, the individual organellesof each blastomere including the nucleus, nucleoli, mitochondria,endoplasmic reticulum, and cytoskeleton, as well as any cellularfragments or extracellular matrix present between the blastomeres orother cellular features such as plaques/boli.

Detailed physical parameters to be measured include, without limitation,size, mass, density, viscosity, internal pressure, elasticity, responsetime, recoil, complex impedance, frequency response, hysteresis,plasticity, and creep. Surface properties such as static friction,dynamic friction, membrane thickness over time, roughness, and texturecan be obtained. When measuring elasticity, one can look at parameterssuch as elastic modulus, shear modulus, and general stiffness in each ofthe 6 degrees of freedom including compression, expansion, and torsion.

In some aspects, mechanical stimuli are employed to trigger deformationor movement of an embryo or oocyte so that a temporal response can bemeasured. In general, the temporal response can be recorded as geometricchange over time and can reflect the stiffness and/or viscosity of theembryo or oocyte. In some aspects, embryos and oocytes with relativelyhigher stiffness and viscosity are more likely viable.

For instance, FIGS. 2A and 2B illustrate the inflation of a portion ofan embryo under a negative air pressure provided by a pipette that drawsthe portion into the pipette. Within a certain time period, the embryoin FIG. 2A exhibits a relatively larger inflation (i.e., greateraspiration depth) as compared to that in FIG. 2B. Accordingly, theembryo of FIG. 2B can be predicted to be more likely viable than theembryo of FIG. 2A which was confirmed with experimental data.

The temporal response of an embryo or oocyte can be represented as ageometric change over time curve, as illustrated in FIG. 3A. In FIG. 3A,the x-axis is time and the y-axis, in this particular example, isaspiration depth. Such a curve can then be fitted into a linear elasticsolid model, such as one shown in FIG. 3B. The linear elastic solidmodel, also referred to as the Zener model, is a method of modeling thebehavior of a viscoelastic material using a linear combination ofsprings and dashpots to represent elastic and viscous components,respectively.

The linear elastic solid model can be represented with the followingequations:

$\begin{matrix}{{{depth} = {F_{0}\lbrack {{\frac{1}{k_{1}}( {1 - {\frac{k_{0}}{k_{0} - k_{1}}^{{- t}/\tau}}} )} - \frac{t}{\eta_{1}}} \rbrack}},{where}} & (A) \\{\tau = {{\eta_{0}( \frac{k_{0} + k_{1}}{k_{0}k_{1}} )}.}} & (B)\end{matrix}$

All parameters, k₀, k₁, τ (or η₀) and η₁, can be determined by fittingthe aspiration depth to the equation above. F₀ is defined as the appliedpressure divided by the area of the pipette opening. Here, the behaviorof an embryo or oocyte is modeled as a combination of solid-like (k₀,k₁) and liquid-like behavior (η₀ and η₁). Therefore, this model allowsmeasurement of both kinds of behavior.

The parameter k₀, together with k₁, describe the “instant elongation”experienced by the embryo or oocyte upon application of a mechanicalstimulus. This instant elongation is 1/(k₀+k₁) as seen in the graph ofFIG. 4, and can be viewed as a measure of the “slack” in the elasticelements of the embryo or oocyte, or the amount of force that can beapplied on it before a marked resistance is exhibited.

The parameter k₁ can be viewed as a general measure of stiffness, andmay represent how tightly the proteins in the cell membrane or zonapellucida are crosslinked.

The parameter η₁ can be viewed as a measure of how much the zonapellucida and cell inside continue to deform in response to the stimulus(FIG. 4). Like in the linear elastic solid model, after the springelements have fully extended, this parameter is responsible for whatevershape changes at the molecular level keep the embryo elongating.

The parameter τ represents how fast (e.g., speed) the embryo or oocytedeforms (e.g., enters the pipette) after the initial instant elongation(FIG. 4), and can be viewed as a measure of the viscosity of thecytoplasm or the fluid in the space between the zona pellucida and thecell inside.

The data presented in the experimental example shows that all of theseparameters, in particular k₁, τ and η₁ and combinations thereof are goodpredicators for the viability of embryos and oocytes.

Mechanical Stimuli

FIG. 2A-2B and FIG. 5A illustrate one form of mechanical stimulus thatcan be applied to an embryo or oocyte for the purpose of viabilityprediction and/or enhancement. Here, a negative air pressure (e.g., alower pressure inside the pipette relative to the pressure inside theembryo or oocyte outside the pipette) is applied to a portion of theembryo or oocyte surface so that that portion inflates into the pipette.

Many other types of mechanical stimuli are also suitable, however. A fewnon-limiting examples are illustrated in FIG. 5B-G. Mechanical stimulican be applied with a needle, or a micropipette, which can be used tocause either negative or positive pressure (aspiration or ejection,respectively) in order to deform, hold, or otherwise perturb the zonapellucida, cytoplasm, or other contents of an embryo or oocyte near itssurface.

Negative or positive pressure can also be applied by another entity,such as the petri dish holding the embryo, or a pressure impulse can beused, similar to a glaucoma test. An embryo or oocyte can also besquashed by a flat sheet with a hole in it and the deformation of themembrane and cytoplasm over time can be measured either while holdingthe sheet steady, or dithering it in various ways (FIG. 5B).

Alternatively, a solid object can be pressed upon one side of the embryoor oocyte against a flat supporting surface, thereby generating a shearpressure by moving horizontally (FIG. 5C). The object here can have avariety of shapes ranging from flat and wide to narrow and rod-like.

The embryo or oocyte can be held still by a micropipette while beingdragged along a surface that can be either smooth or with varyingdegrees of roughness (FIG. 5D). Such a surface can then provide apressure to push the embryo or oocyte into the pipette. Additionally anultrasound transducer can be used to send a pressure wave to perturb theembryo or its contents.

In another embodiment, a flexible cantilever or array of cantilevers ofarbitrary shape can be used to push the embryo or oocyte against asurface, and both the deformation of the embryo's membrane/contents aswell as the cantilever's own deformation can be measured (FIG. 5E, arrowshowing direction of pushing). This will allow one to determine theforce exerted by the embryo on the cantilever. If the stiffness ofvarious components inside the embryo as well as their configurationrelative to each other can be properly measured, the contribution ofeach component to the force exerted back on the cantilever can then bedetermined (e.g., stiffer objects will contribute more).

A similar configuration involves a flexible pipette or pillar where itis pushed either longitudinally or axially into an embryo or oocyte, andits deflection (FIG. 5F) or compression is measured (FIG. 5G).

Optical pressure can also be exerted on various components inside theembryo or on the embryo itself by focusing a beam of light in order tocause a force near its focal point (an optical trap). This will allowone to exert forces originating inside the embryo instead of just at itssurface as with a micropipette, while still remaining non-invasive.Microbeads could also be inserted into the embryo or into the individualblastomeres, and an optical trap can be used to drag them around andpush on various objects.

In some aspects, one can also conduct inertial measurements on an embryoor oocyte by accelerating, bouncing, or rotating the well containing itand observing the movements of its contents relative to each other.Applying hydrostatic pressure to a well or container with an embryo init or placing an embryo in a microfluidic channel while observing theembryo's shape or position over time can yield mechanical information.The embryo can also be stretched by using micropipettes at both ends topull on it, or individual components inside it can be pulled apart usingtwo optical traps to yield information about its stiffness at variousspatial locations. Ballistic testing can also be conducted by launchingmicrobeads at the embryo and observing membrane deformation over time.All of the actions described herein can alternatively be appliedcyclically to measure hysteresis or a loss coefficient over time,without limitation.

Tuning of Mechanical Stimuli

It is contemplated that the mechanical stimuli can to be appliedappropriately with suitable magnitude to provoke a suitable temporalresponse or enhance the viability of the embryo or oocyte. For instance,a force that is too large may reduce the viability of an embryo oroocyte, or even destroy them. A force that is too small may not provokeenough temporal response for the purpose of deriving meaningfulmeasurements. Such information can be obtained by experimental testing.

For a human embryo or oocyte, it is determined that when a positive ornegative pressure is applied, the suitable range of pressure is betweenabout 0.3 psi and about 1 psi (or between about −0.3 psi and about −1psi for a negative pressure). In some aspects, the pressure is at leastabout 0.4, about 0.5, about 0.6 or about 0.7 psi (likewise for negativepressure). In some aspects, the pressure is not higher than about 1,about 0.9, about 0.8, about 0.7, about 0.6, or about 0.5 psi. (likewisefor negative pressure). In some aspects, the human embryo suitable forsuch a pressure is about 1 day, about 2 days or about 3 days followingfertilization.

In some aspects, it is contemplated that when a mechanical stimulus isapplied, for instance, by applying a pressure, which can be positive ornegative, the pressure is maintained at a substantially constant level.This can be helpful to facilitate recording and determination of thetemporal response exhibited by the embryo or oocyte. As used herein, theterm “substantially constant pressure” means that the pressure ismaintained at a level for a desired period of time such that the maximumvariation (i.e., difference between the maximum pressure or the minimumpressure and the average pressure) does not exceed about 20%, oralternatively about 15%, or alternatively about 10%, or about 5% of theaverage pressure.

Also for a human embryo or oocyte, the suitable size of the area onwhich the mechanical stimulus is applied can be determinedexperimentally. For a human embryo, the size of the surface area can bebetween about 25 μm and about 100 μm in diameter. In some aspects, thesize is at least about 30 μm, 35 μm, 40 μm, 45 μm, 50 μm, 55 μm, or 60μm. In some aspects, the size is not larger than about 100 μm, 95, μm,90 μm, 85 μm, 80 μm, 75 μm, 70 μm, 65 μm, 60 μm, 55 μm, or 50 μm. Insome aspects, the size of the surface area can correspond to theinternal diameter of a pipette used to generate the mechanical stimulus.

Measurement Methods

In one embodiment, the measurement can be carried out with simple lightmicroscopy. In this respect, a high frame rate can be used to capturedetailed time-response curves of the embryo or the oocyte and itscontents as it responds to the mechanical stimuli. Based on such images,static and dynamic mechanical parameters can be measured with thematerial properties of the instruments providing the stimuli.

In some aspects, ultrasound can be used to observe the movements of theembryo. Mechanical sensors such as MEMS devices or fiber optic sensorssuch as fiber Bragg gratings, photonic crystal fibers, or fiber opticchemical or pressure sensors can also be used to extract informationabout forces, vibrations, or texture at various spatial locations. Otherproperties of the embryo can be measured as a strain gauge. The pressureof the media surrounding the embryo can be determined with conventionalpressure sensors. Further, accelerometers can be used to calculatevarious movements or parameters such as resonant frequency. Moreover,various combinations of these techniques can provide a more completeimage of spatial and temporal variations in all of the mechanicalproperties.

In some embodiments, the embryos or oocytes are assessed by measuringcell parameters by time-lapse imaging (FIG. 6A). The embryos or oocytesmay be cultured in standard culture dishes. Alternatively, the embryosor oocytes may be cultured in custom culture dishes, e.g. custom culturedishes with optical quality micro-wells (see, e.g., FIG. 6B). In suchcustom culture dishes, each micro-well holds a single embryo/oocyte, andthe bottom surface of each micro-well has an optical quality finish suchthat the entire group of embryos within a single dish can be imagedsimultaneously by a single miniature microscope with sufficientresolution to follow the cell mitosis processes. The entire group ofmicro-wells shares the same media drop in the culture dish, and can alsoinclude an outer wall positioned around the micro-wells for stabilizingthe media drop, as well as fiducial markers placed near the micro-wells.The hydrophobicity of the surface can be adjusted with plasma etching oranother treatment to prevent bubbles from forming in the micro-wellswhen filled with media. Regardless of whether a standard culture dish ora custom culture dish is utilized, during culture, one or moredeveloping embryos may be cultured in the same culture medium.

Images are acquired over time, and are then analyzed to arrive atmeasurements of the one or more cellular parameters. Time-lapse imagingmay be performed with any computer-controlled microscope that isequipped for digital image storage and analysis, for example, invertedmicroscopes equipped with heated stages and incubation chambers, orcustom built miniature microscope arrays that fit inside a conventionalincubator. The array of miniature microscopes allows the concurrentculture of multiple dishes of samples in the same incubator, and isscalable to accommodate multiple channels with no limitations on theminimum time interval between successive image capture. Using multiplemicroscopes eliminates the need to move the sample, which improves thesystem accuracy and overall system reliability. The individualmicroscopes in the incubator can be partially or fully isolated,providing each culture dish with its own controlled environment. Thisallows dishes to be transferred to and from the imaging stations withoutdisturbing the environment of the other samples.

The imaging system for time-lapse imaging may employ brightfieldillumination, darkfield illumination, phase contrast, Hoffman modulationcontrast, differential interference contrast, or fluorescence. In someembodiments, darkfield illumination may be used to provide enhancedimage contrast for subsequent feature extraction and image analysis. Inaddition, red or near-infrared light sources may be used to reducephototoxicity and improve the contrast ratio between cell membranes andthe inner portion of the cells.

Images that are acquired may be stored either on a continuous basis, asin live video, or on an intermittent basis, as in time lapsephotography, where a subject is repeatedly imaged in a still picture. Insome aspects, the time interval between images should be between 0.001second to 0.1 second in order to capture the geometric changes. In analternative embodiment, the time interval between images can be varieddepending on the type and magnitude of the mechanical stimulus.

For the purposes of IVF, it is considered advantageous that the embryobe transferred to the uterus early in development, e.g. by day 1, day 2or day 3, i.e. up through the 8-cell stage, to reduce embryo loss due todisadvantages of culture conditions relative to the in vitroenvironment, and to reduce potential adverse outcomes associated withembryonic arrest, epigenetic errors, or other factors that may disturbembryo viability during culturing. Accordingly, it is preferable thatthe measurement of the temporal parameters take place within 1 or 2 daysof fertilization, although longer periods of analysis, e.g. about 36hours, about 54 hours, about 60 hours, about 72 hours, about 84 hours,about 96 hours, or more, are also contemplated by the present methods.

Determining Viability from Measurements

As discussed above, one or more parameters may be measured and employedto determine the developmental potential (e.g., viability) of an embryoor oocyte. Without limitation, such parameters include k₀, k₁, τ (or η₀)and η₁. In some embodiments, a measurement of a single parameter may besufficient to arrive at a determination of developmental potential. Insome embodiments, it may be desirable to employ measurements of morethan one parameter, for example, 2 parameters, 3 parameters, or 4 ormore parameters. In some embodiments, the two or more parameters includek₁ and η₁. In some embodiments, the three or more parameters include k₁,τ and η₁.

When one parameter is used, or multiple parameters are usedindividually, the determination of viability can be made with comparisonto a suitable control, or based on comparison among a few embryos oroocytes in a group. As provided, a suitable control can be a particularsample or a virtual sample generated by pooling information from a groupof control samples.

For instance, if k₁ alone is used, between two embryos, the one with ahigher k₁ value is more likely to be viable than the other.Alternatively, a pool of embryos, generated under similar conditions andfrom similar donors, can be used to produce a cutoff k₁ value thatseparates viable embryos from non-viable embryos. Any k₁ value that isgreater than this cutoff value predicts that the corresponding embryo islikely viable, and any k₁ value that is lower than this cutoff valuepredicts that the corresponding embryo is not likely viable.

In some aspects, a cutoff range can be used, where the range can begenerated from a group of known samples. In this respect, for instance,if a value falls within the range, the value predicts that the embryo oroocyte is viable; otherwise, if the value is beyond the range, aprediction that the embryo or oocyte is non-viable can be made.

The determination can also be made without predetermined cutoff values,cutoff ranges, or other types of summary statistical data obtained fromreference samples. For instance, the k₁ value of a test embryo can becompared to a group of embryos with known k₁ values and viabilities. Anon-parametric method, such as nearest neighbor, can then readilydetermine the likelihood of the test embryo to be viable or non-viablebased on comparison of these samples. In this respect, the methodentails, after measuring the temporal response from a test sample,comparing the measurement of the test sample to a plurality of sampleswith known viability and measurements of the temporal responses.

Multivariate methods are capable of making such determination with twoor more parameters. Such methods include, without limitation, nearestneighbor, random forest, support vector machine, linear or quadraticdiscriminant analysis and neuron network. In some aspects,visualization, such as principal component analysis, can assist suchdetermination.

In certain embodiments, use of multiple parameters may be desirable asassaying for multiple parameters may provide for greater sensitivity andspecificity. By sensitivity it is meant the proportion of actualpositives which are correctly identified as being such. This may bedepicted mathematically as the number of true positives divided by thesum of number of true positive and number of false negatives.

Thus, in a method in which “positives” are the embryos or oocytes thathave good developmental potential, i.e. that will develop intoblastocysts, and “negatives” are the embryos or oocytes that have poordevelopmental potential, i.e. that will not develop into blastocysts, asensitivity of 100% means that the test recognizes all embryos that willdevelop into blastocysts as such. In some embodiments, the sensitivityof the assay may be about 70%, 80%, 90%, 95%, 98% or more, e.g. 100%. Byspecificity it is meant the proportion of negatives which are correctlyidentified as such. This may be depicted mathematically as the number oftrue positives divided by the sum of number of true negatives and numberof false positives.

Thus, in a method in which positives are the embryos or oocytes thathave good developmental potential, i.e. that will develop intoblastocysts, and negatives are the embryos or oocytes that have poordevelopmental potential, i.e. that will not develop into blastocysts, aspecificity of 100% means that the test recognizes all embryos that willnot develop into blastocysts, i.e. will arrest prior to the blastocyststage, as such. In some embodiments, the specificity of the assay may beabout 70%, 80%, 90%, 95%, 98% or more, e.g. 100%.

In some embodiments, the assessment of an embryo or oocyte includesgenerating a written report that includes the artisan's assessment ofthe subject embryo/oocyte, e.g. a “developmental potential assessment”,an “assessment of chromosomal abnormalities”, etc. Thus, a subjectmethod may further include a step of generating or outputting a reportproviding the results of such an assessment, which report can beprovided in the form of an electronic medium (e.g., an electronicdisplay on a computer monitor), or in the form of a tangible medium(e.g., a report printed on paper or other tangible medium).

A “report,” as described herein, is an electronic or tangible documentwhich includes report elements that provide information of interestrelating to an assessment arrived at by methods of the disclosure. Asubject report can be completely or partially electronically generated.A subject report includes at least an assessment of the developmentalpotential of the subject embryo or oocyte, an assessment of theprobability of the existence of chromosomal abnormalities, etc. Asubject report can further include one or more of: 1) informationregarding the testing facility; 2) service provider information; 3)subject data; 4) sample data; 5) a detailed assessment report section,providing information relating to how the assessment was arrived at,e.g. a) cell parameter measurements taken, b) reference values employed,if any; and 6) other features.

The report may include a subject data section, including medical historyof subjects from which oocytes or oocytes were harvested, patient age,in vitro fertilization cycle characteristics (e.g. fertilization rate,day 3 follicle stimulating hormone (FSH) level), and, when oocytes areharvested, zygote/embryo cohort parameters (e.g. total number ofembryos). This subject data may be integrated to improve embryoassessment and/or help determine the optimal number of embryos totransfer. The report may also include administrative subject data (thatis, data that are not essential to the assessment of developmentalpotential) such as information to identify the subject (e.g., name,subject date of birth (DOB), gender, mailing and/or residence address,medical record number (MRN), room and/or bed number in a healthcarefacility); insurance information, and the like), the name of thesubject's physician or other health professional who ordered theassessment of developmental potential and, if different from theordering physician, the name of a staff physician who is responsible forthe subject's care (e.g., primary care physician).

The report may include a sample data section, which may provideinformation about the biological sample analyzed in the assessment, suchas the type of sample (embryo or oocyte, and stage of oocyte), how thesample was handled (e.g. storage temperature, preparatory protocols) andthe date and time collected. Report fields with this information cangenerally be populated using data entered by the user, some of which maybe provided as pre-scripted selections (e.g., using a drop-down menu).

The report may include an assessment report section, which may includeinformation relating to how the assessments/determinations were arrivedat as described herein. The interpretive report can include, forexample, time-lapse images of the embryo or oocyte being assessed,and/or gene expression results. The assessment portion of the report canoptionally also include a recommendation(s) section. For example, wherethe results indicate good developmental potential of an embryo, therecommendation can include a recommendation that a limited number ofembryos be transplanted into the uterus during fertility treatment asrecommended in the art.

It will also be readily appreciated that the reports can includeadditional elements or modified elements. For example, where electronic,the report can contain hyperlinks which point to internal or externaldatabases which provide more detailed information about selectedelements of the report. For example, the patient data element of thereport can include a hyperlink to an electronic patient record, or asite for accessing such a patient record, which patient record ismaintained in a confidential database. This latter embodiment may be ofinterest in an in-hospital system or in-clinic setting. When inelectronic format, the report is recorded on a suitable physical medium,such as a non-transitory computer readable storage medium, e.g., in acomputer memory, zip drive, CD, DVD, etc. Aspects of viabilitydetermination using one or more parameters can be carried out usingcomputer code or instructions embodied in a non-transitory computerreadable storage medium.

It will be readily appreciated that the report can include all or someof the elements above, with the proviso that the report generallyincludes at least the elements sufficient to provide the analysisrequested by the user (e.g., an assessment of developmental potential).

Utility

As discussed above, methods of the disclosure may be used to assessembryos or oocytes to determine their developmental potential. Thisdetermination of developmental potential may be used to guide clinicaldecisions and/or actions. For example, in order to increase pregnancyrates, clinicians often transfer multiple embryos into patients,potentially resulting in multiple pregnancies that pose health risks toboth the mother and fetuses. Using results obtained from the methods ofthe disclosure, the developmental potential of embryos being transferredto develop into fetuses is determined prior to transfer, allowing thepractitioner to decide which and how many embryos to transfer so as tomaximize the chance of success of a full term pregnancy while minimizingrisk.

Assessments made by the present methods may also find use in rankingembryos or oocytes in a group of embryos or oocytes for theirdevelopmental potential. For example, in some instances, multipleembryos may be capable of developing into blastocysts, i.e. will havegood developmental potential. However, some embryos will be more likelyto achieve the blastocysts stage or a higher-quality blastocyst thanother, i.e. they will have better developmental potential than otherembryos. In such cases, the present methods may be used to rank theembryos in the group. In such methods, one or more parameters for eachembryo/oocyte is measured and compared. The parameters are then employedto determine the developmental potential of the embryos or oocytesrelative to one another. In some embodiments, the parameter measurementsfrom each of the embryos or oocytes are employed by comparing themdirectly to one another to determine the developmental potential of theembryos or oocytes. In some embodiments, the parameter measurements fromeach of the embryos or oocytes are employed by comparing the cellparameter measurements to a parameter measurement from a referenceembryo/oocyte to determine the developmental potentials for eachembryo/oocyte, and then comparing the determined developmentalpotentials for each embryo/oocyte to determine the developmentalpotential of the embryos or oocytes relative to one another. In thisway, a practitioner assessing, for example, multiple zygotes/embryos,can choose only the best quality embryos, i.e. those with the bestdevelopmental potential, to transfer so as to maximize the chance ofsuccess of a full term pregnancy while minimizing risk.

Assessments made by following the methods of the disclosure may alsofind use in determining the developmental potential of oocytes that arematured in vitro and stem cells that are cultured in vitro. Informationon the developmental potential of oocytes obtained by the methods of thedisclosure can guide the practitioner's selection of ooctyes tofertilize, resulting in higher probability of success in derivingblastocysts from these oocytes.

Reagents, Devices and Kits

Also provided are reagents, devices and kits thereof for practicing oneor more of the above-described methods. The subject reagents, devicesand kits thereof may vary greatly. Reagents and devices of interestinclude those mentioned above with respect to the methods of measuringany of the aforementioned cell parameters, where such reagents mayinclude culture plates, culture media, microscopes, imaging software,imaging analysis software, nucleic acid primers, arrays of nucleic acidprobes, antibodies, signal producing system reagents, etc., depending onthe particular measuring protocol to be performed.

In addition to the above components, the subject kits will furtherinclude instructions for practicing the subject methods. Theseinstructions may be present in the subject kits in a variety of forms,one or more of which may be present in the kit. One form in which theseinstructions may be present is as printed information on a suitablemedium or substrate, e.g., a piece or pieces of paper on which theinformation is printed, in the packaging of the kit, in a packageinsert, etc. Yet another means would be a computer readable medium,e.g., diskette, CD, etc., on which the information has been recorded.Yet another means that may be present is a website address which may beused via the internet to access the information at a removed site. Anyconvenient means may be present in the kits.

EXAMPLES

The present disclosure will be understood more readily by reference tothe following examples, which are provided by way of illustration andare not intended to be limiting.

Example 1

This example used a micropipette to perform aspiration on mouse embryoswith a step pressure input and used a time-lapse imaging system tomeasure the aspiration depth of a portion of mouse embryos.

Materials and Methods

Micropipettes (40 μm diameter opening) were used to perform aspirationon mouse embryos and oocytes a few hours before and after fertilization(see, e.g., FIG. 2A-B). Mechanical measurements were conducted for thetemporal response (i.e., aspiration depth of inflation) generated by theaspiration. Aspiration curves were fitted to a 4-parameter mechanicalmodel, statistical analyses were conducted using student's t-test andchi-square goodness of fit test.

After embryos were measured, they were either placed in the time-lapseimaging system (FIG. 6A) to see if they develop to the blastocyst stage,or placed in the time lapse system for 2 days (until the system predictsviability) and then gene expression analysis was performed. Geneexpression analysis was conducted with Fluidigm's single-cell analysissystem and qPCR.

These methods were useful in determining correlation between mechanicalmeasurements and viability, and which mechanical measurements arecorrelated to which gene expression patterns, and which gene expressionpatterns are correlated to viability.

For mouse oocytes, upon such measurement, they were allowed to undergoIVF and then followed the same procedure as embryos.

This example, in one study, uses survival to blastocyst stage andtime-lapse imaging parameters as a measure of viability. This showswhich mechanical parameters are predictive of survival to day 5 inculture. Meanwhile, high-throughput, single cell qPCR analysis wereconducted on embryos at 1, 2 and 4-cell stages to identify whichmechanical parameters or time-lapse parameters are predictive of geneexpression patterns associated with high developmental competence.

The different experimental groups tested included:

1. Embryos measured at day 1, left to develop to blast;

2. Embryos measured at day 1, expression profiles at day 1;

3. Embryos measured at day 1, time lapse+expression profiles at day 2;

4. Controls, left to develop to blast;

5. Controls, expression profiles at day 1;

6. Controls, time lapse+expression profiles at day 2.

Results

For each sample, an aspiration curve was drawn taking the aspirationdepth as y-axis and time as x-axis (FIG. 7B). When all the curves werecombined, it is apparent that viable embryos (those that developed intoblastocysts) exhibited lower aspiration depth overall and had a moreflat curve than the non-viable embryos (compare the shaded areas in FIG.7A). The asterisks in FIG. 7B indicate a concentrated area where viableembryos are located, whereas the non-viable ones have a more diversedistribution.

Each of these aspiration curves was then fitted to a linear elasticsolid model with equations (A) and (B) as shown above, and theparameters (k₀, k₁, τ and η₁) were resolved by such fitting. Theparameters were then compared among samples. FIG. 8 shows that viableembryos generally have higher k₁ values and lower η₁ and τ values.Further, as shown in FIG. 8, both of these three parameters,independently, have great discrimination (predictive) power.

When in combination, k₁ and η₁ showed even greater prediction power. Asshown in the scatter plot in FIG. 9, when used together, k₁ and η₁clearly separate viable embryos from non-viable ones. Still further,when three parameters, k₁, τ and η₁ are used, the separation is evenmore clear (FIG. 10).

The predicative power of these parameters was tested by dividing thesample set into a training set (70% samples) and a testing set (30%samples). An elliptical region on a 3D scatter plot was selected to bestseparate the viable embryos from non-viable embryos. For the purpose ofthis study, the selection was made to maximize specificity. As shown inFIG. 11A, the specificity of the elliptical region was 100%. Thesensitivity, meanwhile, was as high as 41.8%.

When the elliptical region was applied to the testing set, a 100%specificity was also obtained, while the sensitivity remained at 42.3%(FIG. 11B), confirming the predicative power of these parameters, withrespect to viability of the embryos.

The same comparison is shown in FIG. 12 for embryos measured at theone-cell stage, indicating that the same method can be predictive inearly stage embryos.

What is more interesting, and surprising as well, is that the sameparameters can be used to distinguish oocytes that fertilized intoviable embryos from those that did not (FIGS. 13 and 14). Nevertheless,it was observed that oocytes, in general, had lower stiffness thanembryos (FIG. 15) suggesting that the cutoff values for oocytes shouldbe tuned from those obtained from embryos. Even without tuning, however,good distinction can be made with these parameters with mixed sample(FIG. 16), showing the great predictive power of these parameters.

For all these experiments, the predicative accuracy can be furtherassessed with gene expression assay and analysis. It is contemplatedthat expression changes of the tested genes can be profiled, asillustrated as a heat map in FIG. 17. In the heat map, for instance, agroup of genes (indicated by an asterisk) are co-clustered, suggestingthat they are co-regulated in a pathway. Gene ontology study of thepathway, it is further contemplated, can suggest that the pathway isrelated to viability of the embryo. Therefore, such a gene expressionprofiling analysis can be used to and is expected to validate theparameters.

From these experiments, it was also observed that embryos that receivedthe aspiration, in general, showed improved viability relative to thosethat did not receive the aspiration. Therefore, it was an unexpectedfinding that such mechanical manipulation is beneficial to embryodevelopment and has clinical implications.

Moreover, the tables below summarize the findings from differentexperiment groups, and suggest that the size of the pipette and themagnitude of the pressure can also affect the prediction accuracy andevaluation of the values of the parameters.

30 um pipette, 0.7 psi pressure:

Date 6/21 6/27 7/12 7/26 Totals Control Group 3/6 2/5 6/8  6/10 17/29(Lived) (50%) (40%) (75%) (60%) (59%) Experimental 10/16  7/13 17/1916/20 50/68 Group (Lived) (63%) (54%) (89%) (80%) (74%)40 um pipette, 0.2 psi pressure:

Date 10/15 11/1 11/5 Totals Control Group 4/6 5/6 5/6 14/18 (Lived)(66%) (83%) (83%) (78%) Experimental 13/15 14/15 13/15 40/45 Group(Lived) (87%) (93%) (87%) (89%)40 um pipette, 0.4 psi pressure:

Date 11/30 Totals Control Group 28/43 28/43 (Lived) (65%) (65%)Experimental 23/35 23/35 Group (Lived) (66%) (66%)

In summary, this example shows that mechanical measurements right beforeand after fertilization can be used as a biomarker for embryo viabilityand cytoplasmic maturation.

This example deals mostly with deriving information about the zonapellucida which forms relatively early in development. Still, earlydeficiencies in proper gene expression can cause the embryo to havecompromised developmental competence later on, so that is why themeasurement can be indicative or predictive of viability. The mechanicalproperties of the oocyte or embryo also influence the aspiration curves,even though this example was aspirating from the outside and obtainedinformation mostly about the zona pellucida.

This study will lead to a good predictor of viability, which will giveclinicians the information to pick a single embryo to implant if manyare viable, or how many to implant if all have low viability. It alsoprovides interesting insight about how a cell's outer mechanicalproperties are indicative of its functioning on a molecular scale, aswell as how mechanical stimuli can influence a cell's function orpossibly rescue a dying cell.

The contents of the articles, patents, and patent applications, and allother documents and electronically available information mentioned orcited herein, are hereby incorporated by reference in their entirety tothe same extent as if each individual publication was specifically andindividually indicated to be incorporated by reference.

Applicants reserve the right to physically incorporate into thisapplication any and all materials and information from any sucharticles, patents, patent applications, or other physical and electronicdocuments.

The disclosures illustratively described herein may suitably bepracticed in the absence of any element or elements, limitation orlimitations, not specifically disclosed herein. Thus, for example, theterms “comprising”, “including,” containing”, etc. shall be readexpansively and without limitation. Additionally, the terms andexpressions employed herein have been used as terms of description andnot of limitation, and there is no intention in the use of such termsand expressions of excluding any equivalents of the features shown anddescribed or portions thereof, but it is recognized that variousmodifications are possible within the scope of the claims. Thus, itshould be understood that although the present disclosure has beenspecifically disclosed by preferred embodiments and optional features,modification and variation of the disclosures embodied therein hereindisclosed may be resorted to by those skilled in the art, and that suchmodifications and variations are considered to be within the scope ofthis disclosure.

The disclosure has been described broadly and generically herein. Eachof the narrower species and subgeneric groupings falling within thegeneric disclosure also form part of the disclosure. This includes thegeneric description of the disclosure with a proviso or negativelimitation removing any subject matter from the genus, regardless ofwhether or not the excised material is specifically recited herein.Other embodiments are within the following claims. In addition, wherefeatures or aspects of the disclosure are described in terms of Markushgroups, those skilled in the art will recognize that the disclosure isalso thereby described in terms of any individual member or subgroup ofmembers of the Markush group.

1-20. (canceled)
 21. A method for determination of a viability of amammalian embryo or a potential embryo generated from a mammalianoocyte, comprising: performing aspiration on a portion of a surface ofthe embryo or oocyte to inflate the embryo or oocyte; detecting atemporal response of the embryo or oocyte to the aspiration using amicroscope, the temporal response including aspiration depths of theembryo or oocyte as a function of time; and deriving measurements forone or more parameters from the temporal response, the measurementsbeing indicative of viability.
 22. The method of claim 21, wherein theone or more parameters include at least one of speed and depth ofinflation.